Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. Note Purchase Agreement and Promissory Note On January 13, 2026, HeartSciences Inc. (the “Company” entered into a No
. 1 Item 3.02 Unregistered Sales of Equity Securities To the extent required by Item 3.02 of Form 8-K, the information contained in Item 1.01 above is incorpora
. The Company issued the Note to Streeterville in reliance on the exemption from registration provided for under Section 4(a)(2) of the Securities Act of 1933,
Financial Statements and Exhibits (a) Exhibits Number Description 10.1* Note Purchase Agreement, by and between the Company and Streeterville Capital, LLC dated